NCT04382040 - A Phase II, Controlled Clinical Study Designed to Evaluate the Effect of ArtemiC in Patients Diagnosed With COVID-19 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 8, 2020

Primary Completion Date

November 5, 2020

Study Completion Date

December 21, 2020

Conditions

COVID-19Corona Virus InfectionSARS-CoV 2CoronavirusCoronavirus Infection

Interventions

DRUG

ArtemiC

Treatment will be sprayed orally twice a day for the first 2 days in the treatment period

DRUG

Placebo

Treatment will be sprayed orally twice a day for the first 2 days in the treatment period

Trial Locations (4)

Nazareth Hospital EMMS, Nazareth

Rambam Health Care Campus, Haifa

Hillel Yaffe Medical Center, Hadera

Mahatma Gandhi Mission Medical College and Hospital, Aurangabad